MVM. N. Valiakhmetov

M. N. Valiakhmetov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. N. Valiakhmetov has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Array V. Zagrebelnyy

    National Medical Research Center for Preventive Medicine

    1 shared publication
  • D. N. Jilin

    Тула, ул. Яблочкова Тульская областная клиническая больница Россия 300053 1а

    1 shared publication
  • E. E. Fedotova

    Тула, ул. Яблочкова Тульская областная клиническая больница Россия 300053 1а

    1 shared publication
  • E. V. Kudryashov

    Петроверигский пер Национальный медицинский исследовательский центр профилактической медицины Россия 10 101990 Москва

    1 shared publication
  • K. N. Nadejkina

    Тула, ул. Яблочкова Тульская областная клиническая больница Россия 300053 1а

    1 shared publication
  • M. M. Luk'YAnov

    National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation

    1 shared publication

Latest Publications

  • Open Access

    PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY)

    by M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, Array V. Zagrebelnyy, E. V. Kudryashov, et al.

    Aim. To determine the proportion of patients with atrial fibrillation (AF) among hospitalized patients in the departments of the multidisciplinary hospital and to study the structure of the associated cardiovascular diseases (CVD) and drug therapy within the RECVAZA AF-Tula hospital registry. Material and methods. All patients with a diagnosis of AF in the patient's chart (n=1225) were included into the RECVAZA AF-Tula registry; that is 4.2% of 29018 patients hospitalized to the Tula Regional Clinical Hospital in 2013. The structure of the associated cardiovascular diseases, as well as drug therapy, was evaluated on the basis of data in the medical documentation. Results. The mean age of patients with AF was 69.6±9.9 years, men was 47.8%. 87.5% of patients had a combination of AF with hypertension, 75.1% – with ischemic heart disease, and 81.4% – with chronic heart failure. The average number of diagnoses was 3.4 per patient. The proportion of patients with permanent, persistent and paroxysmal forms of AF was 46.4%, 20%, and 29%, respectively. The risk score according to the CHA2DS2-VASc and HAS-BLED scales was higher in patients of therapeutic profile (4.27±1.66 and 1.48±0.95) than this in patients of surgical profile (3.57±1.70 and 1.06±0.74, pConclusion. Patients with AF accounted for 4.2% of all hospitalized patients in a multidisciplinary hospital. The proportion of patients with AF in the therapeutical departments was 4 times more than that in the surgical departments. Most patients enrolled in the registry had associated CVD. The compliance of drug therapy of CVD to clinical guidelines was insufficient, especially at the outpatient stage, as well as in the surgical departments of the hospital.